|
SLC4A1AP expression based on
|
KIRP : Kidney renal papillary cell carcinoma
| Comparison | Statistical significance |
| Normal-vs-Primary | 1.925590E-01 |
|
KIRP : Kidney renal papillary cell carcinoma Note
Cancer stage information is not available for 89 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Stage1 |
6.840400E-02 |
| Normal-vs-Stage2 |
6.315200E-01 |
| Normal-vs-Stage3 |
5.853200E-01 |
| Normal-vs-Stage4 |
4.425600E-01 |
| Stage1-vs-Stage2 |
5.888600E-01 |
| Stage1-vs-Stage3 |
9.214400E-02 |
| Stage1-vs-Stage4 |
8.905400E-01 |
| Stage2-vs-Stage3 |
4.432800E-01 |
| Stage2-vs-Stage4 |
6.395000E-01 |
| Stage3-vs-Stage4 |
3.217000E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma Note
Patient race information is not available for 15 samples and two samples from American Indians not included in the above plot.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Caucasian |
1.504020E-01 |
| Normal-vs-AfricanAmerican |
5.228000E-01 |
| Normal-vs-Asian |
7.184000E-01 |
| Caucasian-vs-AfricanAmerican |
6.432600E-01 |
| Caucasian-vs-Asian |
3.534600E-01 |
| AfricanAmerican-vs-Asian |
4.371400E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Male |
2.047700E-02 |
| Normal-vs-Female |
2.011600E-01 |
| Male-vs-Female |
6.586000E-04 |
|
|
KIRP : Kidney renal papillary cell carcinoma Note
Patient BMI information is not available for 72 samples.
| Descriptions |
| Normal weight |
BMI greater than equal to 18.5 and BMI less than 25 |
Extereme weight |
BMI greater than equal to 25 and BMI less than 30 |
| Obese |
BMI greater than equal to 30 and BMI less than 40 |
Extreme Obese |
BMI greater than 40 |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Normal_Weight |
2.454100E-02 |
| Normal-vs-Extreme_Weight |
1.117820E-02 |
| Normal-vs-Obese |
8.332000E-01 |
| Normal-vs-Extreme_Obese |
4.490200E-01 |
| Normal_Weight-vs-Extreme_Weight |
8.091600E-01 |
| Normal_Weight-vs-Obese |
3.949600E-02 |
| Normal_Weight-vs-Extreme_Obese |
7.277400E-01 |
| Extreme_Weight-vs-Obese |
2.082400E-02 |
| Extreme_Weight-vs-Extreme_Obese |
7.990600E-01 |
| Obese-vs-Extreme_Obese |
4.010000E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma Note
Patient age information is not available for 3 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Age(21-40Yrs) |
3.082000E-01 |
| Normal-vs-Age(41-60Yrs) |
7.318600E-01 |
| Normal-vs-Age(61-80Yrs) |
3.989900E-02 |
| Normal-vs-Age(81-100Yrs) |
2.720000E-01 |
| Age(21-40Yrs)-vs-Age(41-60Yrs) |
1.923040E-01 |
| Age(21-40Yrs)-vs-Age(61-80Yrs) |
4.561900E-02 |
| Age(21-40Yrs)-vs-Age(81-100Yrs) |
1.213980E-01 |
| Age(41-60Yrs)-vs-Age(61-80Yrs) |
8.627700E-02 |
| Age(41-60Yrs)-vs-Age(81-100Yrs) |
3.528600E-01 |
| Age(61-80Yrs)-vs-Age(81-100Yrs) |
8.831000E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma NOTE
Histology information is not available for 17 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-VS-Type1 PRCC |
1.277170E-01 |
| Normal-VS-Type2 PRCC |
2.780200E-01 |
| Normal-VS-KIRP CIMP |
6.114200E-01 |
| Normal-VS-Unclassified PRCC |
5.055200E-01 |
| Type1 PRCC-VS-Type2 PRCC |
9.694400E-01 |
| Type1 PRCC-VS-KIRP CIMP |
2.509000E-01 |
| Type1 PRCC-VS-Unclassified PRCC |
8.334300E-02 |
| Type2 PRCC-VS-KIRP CIMP |
3.399400E-01 |
| Type2 PRCC-VS-Unclassified PRCC |
1.752190E-01 |
| KIRP CIMP-VS-Unclassified PRCC |
9.388200E-01 |
|
Histologic PRCC subtypes: Ricketts CJ et al, The Cancer Genome Atlas Comprehensive Molecular Characterization of Renal Cell Carcinoma. Cell Rep. 2018 Apr 3;23(1):313-326.e5. doi: 10.1016/j.celrep.2018.03.075
|
KIRP : Kidney renal papillary cell carcinoma Note
Nodal metastais status is not available for 1 sample and cancer in nearby lymph nodes cannot be measured (NX) in 211 samples.
| pathologic_N descriptions |
| N0 | No regional lymph node metastasis |
N1 | Metastases in 1 to 3 axillary lymph nodes |
| N2 | Metastases in 4 to 9 axillary lymph nodes |
N3 | Metastases in 10 or more axillary lymph nodes |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-N0 |
1.172270E-02 |
| Normal-vs-N1 |
1.624640E-01 |
| Normal-vs-N2 |
2.110200E-01 |
| N0-vs-N1 |
1.598260E-02 |
| N0-vs-N2 |
9.123600E-01 |
| N1-vs-N2 |
3.117600E-01 |
|
|
